$5.79
6.91%
Nasdaq, Oct 19, 03:56 pm EDT. Closed.
ISIN
US67092M2089
Symbol
NTRB

Nutriband Stock price

$6.00
-1.77 22.78% 1M
+1.80 42.86% 6M
+1.46 32.16% YTD
-1.25 17.24% 1Y
+4.14 223.10% 3Y
+1.52 33.79% 5Y
+1.47 32.58% 10Y
+1.47 32.58% 20Y
Nasdaq, Closing price Mon, Oct 19 2026
-0.22 3.54%
ISIN
US67092M2089
Symbol
NTRB
Industry

Is Nutriband a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
$75.6m
Enterprise Value
$72.3m
Net debt
positive
Cash
$3.4m
Shares outstanding
12.2m
Valuation
P/E
negative
P/S | estimate
46.7 | 0.8
EV/Sales | estimate
44.7 | 0.7
EV/FCF | ex SBC
negative | negative
P/B
14.2
Financial Health
Equity Ratio
88.5%
Return on Equity
-449.8%
ROCE
-131.0%
ROIC
-330.8%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$3.5m | 216.7%
SBC as % of FCF
-
SBC Growth 1Y
-
Share Count Growth 1Y
1.2%
Shareholder Yield
-1.2%
Financials
Revenue | estimate
$1.6m | $97.3m
EBITDA
$-6.9m
EBIT
$-7.0m
Net Income
$-7.0m
Free Cash Flow | ex SBC
$-3.6m | $-7.1m
Growth
Revenue | estimate
-37.2% | 4,670.5%
EBITDA
-5.3%
EBIT
-3.5%
Net Income
78.3%
Free Cash Flow
26.7%
Margin
Gross
33.1%
EBITDA
-426.5%
EBIT
-435.6%
Net
-430.4%
Free Cash Flow | ex SBC
-224.5% | -441.6%
More
EPS
$-0.6
FCF per Share
$-0.3
Short interest
2.9%
Employees
13
Rev per Employee
$160.0k

Nutriband Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Nutriband forecast:

Buy
86%
Hold
14%

Financial data from Nutriband

Jul '26
+/-
%
1.62 1.62
37% 37%
100%
- Direct Costs 1.08 1.08
36% 36%
67%
0.54 0.54
39% 39%
33%
- Selling and Administrative Expenses 6.37 6.37
25% 25%
393%
- Research and Development Expense 1.21 1.21
54% 54%
75%
-6.90 -6.90
5% 5%
-426%
- Depreciation and Amortization 0.15 0.15
42% 42%
9%
EBIT (Operating Income) EBIT -7.05 -7.05
4% 4%
-435%
Net Profit -6.96 -6.96
78% 78%
-430%

In millions USD.

Don't miss a Thing! We will send you all news about Nutriband directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nutriband Stock News

Neutral
GlobeNewsWire
●
6 days ago
ORLANDO, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB), announced today that it has seen 272,671 NTRBW warrants exercised at a strike price of $6.43 for proceeds to the company of $1,753,274.53.
Neutral
GlobeNewsWire
●
11 days ago
Nutriband files new non-provisional patent application to strengthen intellectual property protection of its AVERSA™ transdermal abuse deterrent technology being developed for patches containing  opioids and stimulants with a potential for abuse. Nutriband's AVERSA™ abuse-deterrent technology consists of a proprietary aversive agent coating that employs taste aversion to deter oral abuse and re...
Neutral
GlobeNewsWire
●
18 days ago
Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary CEO letter reflects on five years of milestones since the Company's October 1, 2021 uplisting, as AVERSA™ Fentanyl advances toward an IND filing and the 2021 offering warrants expire as scheduled ORLANDO, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) today announced that CEO ...
More Nutriband News

Company Profile

Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It delivers abuse deterrent fentanyl transdermal system which provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. It operates through the Pocono Coated Products and Active Intelligence segments. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2016 and is headquartered in Orlando, FL.

Head office United States
CEO Mr. Sheridan
Employees 13
Founded 2012
Website nutriband.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today